A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss
HIV Infections, HIV Wasting Syndrome
About this trial
This is an interventional treatment trial for HIV Infections focused on measuring Dietary Proteins, HIV Wasting Syndrome
Eligibility Criteria
Inclusion Criteria You may be eligible for this study if you: Are HIV-positive. Are at least 18 years old. Have an HIV level less than 5,000 copies/ml within 30 days of study entry. Have lost weight in the past year, but your weight has remained fairly stable in the 2 months prior to enrollment. Are expected to live for at least 6 months. Are usually able to eat enough to maintain your present weight. Are able to complete a 3-day food diary. Exclusion Criteria You will not be eligible for this study if you: Have gained a significant amount of weight in the past 2 months. Have any opportunistic (HIV-associated) infections. Are unable to eat enough food for any reason, or are on tube feeding. Have nausea, diarrhea, or vomiting in the 14 days prior to study entry. Are being treated for diabetes. Are receiving chemotherapy or radiation therapy to treat cancer. Are pregnant or breast-feeding. Are allergic to milk or mangoes. Have an implanted defibrillator.
Sites / Locations
- Univ of Southern California / LA County USC Med Ctr
- UCLA CARE Ctr
- San Francisco Gen Hosp
- Stanford Univ Med Ctr
- Univ of Colorado Health Sciences Ctr
- Queens Med Ctr
- Univ of Hawaii
- Tulane Univ School of Medicine
- Johns Hopkins Hosp
- St Louis Regional Hosp / St Louis Regional Med Ctr
- Chelsea Ctr
- Cornell Univ Med Ctr
- Univ of Rochester Medical Center
- Univ of Cincinnati
- Ohio State Univ Hosp Clinic
- Philadelphia Veterans Administration Med Ctr
- Julio Arroyo
- Univ of Washington
- Univ of Puerto Rico